stocktools
Dilution profile // every instrument, one screen, from SEC filings

Cellyan Biotechnology Co., Ltd (HKPD)

CIK 2007702 · all EDGAR filings →

Overall dilution risk
HIGHworst of 2 computed signals (offering ability)
= the worst band among the computed sub-ratings, no hidden weighting
not every sub-rating was computable; treat as a floor
Offering ability
HIGH$208M registered
= total registered offering amount from the fee exhibits of live registrations (bands: $1M / $20M)
one or more live registrations had no structured fee data, so the true total is AT LEAST this
Overhead supply
NOT COMPUTEDno warrant count tagged in XBRL
= warrant shares outstanding divided by current shares outstanding
absence of a tag is not proof of absence of warrants
Historical dilution
MEDIUM+49% O/S in 3y
= share count now vs 3 years ago (bands: 30% / 100%); a reverse split pushes this negative
Cash need
NOT COMPUTEDrunway not computable from latest facts
= cash vs trailing operating burn

Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.

Shares outstanding over time

2025-03-312026-03-31

Latest: 16.3M shares as of Mar 31, 2026 (20-F).

Cash runway

Not enough filing data

can’t compute a runway

Full breakdown: cash runway tool

Warrants

No warrant figures tagged in this filer’s XBRL facts. That means the company has not reported them in structured form; it does not prove no warrants exist. The exhibits are the ground truth.

Convertible notes

The latest 10-Q/10-K instance document could not be checked just now, so nothing is shown rather than guessed. Try again shortly.

Registrations and offerings

Registered offering capacity on live registrations: $208.1Mfrom the structured fee exhibits; registered is not remaining, takedowns are not subtracted

F-3Jun 12, 2026$200.0M registeredfiling →
F-1Mar 27, 2026$8.1M registeredfiling →
F-1Oct 29, 2024no structured fee exhibit in this filing (predates fee-data XBRL or fee deferred)filing →

Last 12 months: 0 executed · 2 registered.

EFFECTIVEJun 24, 2026SEC declared a registration effective — selling can beginEFFECT →
REGISTEREDJun 12, 2026F-3 registration — capacity to sell shares, not a sale yetF-3 →
EFFECTIVEApr 8, 2026SEC declared a registration effective — selling can beginEFFECT →
REGISTEREDMar 27, 2026F-1 registration — capacity to sell shares, not a sale yetF-1 →
EXECUTEDJan 15, 2025Final prospectus — offering priced (typical for IPOs and marketed share deals)424B4 →
EFFECTIVEDec 20, 2024SEC declared a registration effective — selling can beginEFFECT →
REGISTEREDDec 10, 2024F-1/A registration — capacity to sell shares, not a sale yetF-1/A →
REGISTEREDNov 27, 2024F-1/A registration — capacity to sell shares, not a sale yetF-1/A →
MARKETINGNov 22, 2024Free-writing prospectus — offering being marketedFWP →
REGISTEREDNov 21, 2024F-1/A registration — capacity to sell shares, not a sale yetF-1/A →
REGISTEREDOct 29, 2024F-1 registration — capacity to sell shares, not a sale yetF-1 →

Full history and shelf status: offering checker · S-3 shelf checker

Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.

Keep going: float checker · offering calendar · short-squeeze screener · full HKPD workspace